Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.
-
The case alleges Kyndryl misstated its financial statements and lacked adequate internal controls.
-
The SLM class action lawsuit alleges that defendants overstated the effectiveness of SLM’s loss mitigation and/or loan modification programs.
-
The case alleges Richtech Robotics claimed that it had a collaborative and commercial relationship with Microsoft when it did not.
-
The case alleges F5 misled investors with false growth outlooks while hiding a major security breach that risked its reputation and future revenue.
-
Robbins Geller is investigating whether Navan and certain of its top executives made materially false and/or misleading statements to investors.
-
The SLM class action lawsuit alleges that defendants overstated the effectiveness of SLM’s loss mitigation and/or loan modification programs.
-
Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.
-
$ARDT ARDT Ardent Health Ardent Health Class Action Lawsuit Ardent Health, Inc. BW: $ARDT ARDT ArdentHealth ArdentHealthClassActionLawsuit ArdentHealthInc
-
The Smartsheet class action alleges that former shareholders approved the company's Merger and received an unfair price due to a misleading Proxy.